✦ LIBER ✦

Molecular Predictors of Outcome With Gefitinib in a Phase III Placebo-Controlled Study in Advanced Non-Small-Cell Lung Cancer

✍ Scribed by Hirsch, F. R.; Varella-Garcia, M.; Bunn, P. A.; Franklin, W. A.; Dziadziuszko, R.; Thatcher, N.; Chang, A.; Parikh, P.; Pereira, J. R.; Ciuleanu, T.; von Pawel, J.; Watkins, C.; Flannery, A.; Ellison, G.; Donald, E.; Knight, L.; Parums, D.; Botwood, N.; Holloway, B.

Book ID: 118037841
Publisher: American Society of Clinical Oncology
Year: 2006
Tongue: English
Weight: 191 KB
Volume: 24
Category: Article
ISSN: 0732-183X
DOI: 10.1200/jco.2006.06.3958

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictors of gefitinib outcomes in adva

Predictors of gefitinib outcomes in advanced non-small cell lung cancer (NSCLC): Study of a comprehensive panel of molecular markers

✍ Tiseo, Marcello; Rossi, Giulio; Capelletti, Marzia; Sartori, Giuliana; Spiritell 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Molecular Predictors of Outcome With Gef

Molecular Predictors of Outcome With Gefitinib and Docetaxel in Previously Treated Non-Small-Cell Lung Cancer: Data From the Randomized Phase III INTEREST Trial

✍ Douillard, J.-Y.; Shepherd, F. A.; Hirsh, V.; Mok, T.; Socinski, M. A.; Gervais, 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 241 KB

Erlotinib as maintenance treatment in ad

Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study

✍ Federico Cappuzzo; Tudor Ciuleanu; Lilia Stelmakh; Saulius Cicenas; Aleksandra S 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 321 KB

Phase II trial of gefitinib in pretreate

Phase II trial of gefitinib in pretreated Chinese women with advanced non-small-cell lung cancer

✍ Jing Deng, Wei Jia Fang, Xiao Chen Zhang, Dong Ping Wu, Hong Ming Fang, Jing Che 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 178 KB

Polymorphisms of EGFR predict clinical o

Polymorphisms of EGFR predict clinical outcome in advanced non-small-cell lung cancer patients treated with Gefitinib

✍ Ma, Fei; Sun, Tong; Shi, Yuankai; Yu, Dianke; Tan, Wen; Yang, Ming; Wu, Chen; Ch 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 547 KB

First-Line Single Agent Treatment With G

First-Line Single Agent Treatment With Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer: A Phase II Study

✍ Niho, S. 📂 Article 📅 2006 🏛 American Society of Clinical Oncology 🌐 English ⚖ 124 KB